30 related articles for article (PubMed ID: 12817625)
21. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
[TBL] [Abstract][Full Text] [Related]
22. Pathways for activation of the ras-oncogene-encoded p21 protein.
Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
[TBL] [Abstract][Full Text] [Related]
23. Peptides That Block RAS-p21 Protein-Induced Cell Transformation.
Pincus MR; Lin B; Patel P; Gabutan E; Zohar N; Bowne WB
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831007
[TBL] [Abstract][Full Text] [Related]
24. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
[TBL] [Abstract][Full Text] [Related]
25. Anti-cancer peptides from ras-p21 and p53 proteins.
Pincus MR; Fenelus M; Sarafraz-Yazdi E; Adler V; Bowne W; Michl J
Curr Pharm Des; 2011; 17(25):2677-98. PubMed ID: 21728981
[TBL] [Abstract][Full Text] [Related]
26. Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins.
Mattingly RR
ISRN Oncol; 2013; 2013():536529. PubMed ID: 24294527
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
